chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pregnant after 1st dose; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant after 1st dose) in a 32-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included LEVOTHYROXINE for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 03-Mar-2021 and the estimated date of delivery was 08-Dec-2021. On 03-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant after 1st dose). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 03-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant after 1st dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Pregnancy test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Due date was reported as Dec 2021.
Nausea, vomiting, fever. ***Then on 3/21/2021 I had severe vertigo than began suddenly. It was severe for about a week. Moderate the next week and is now mild, but still present.
Patient reports pain/swelling in both hands, pain in right arm. Pain in back and neck. Pain in back and neck subsided in an unspecified amount of time, but pain still is in arm and hands as of 8/10/21.
Systemic: Neurological Disorder (diagnosed by MD)-Severe, Additional Details: Patient states that since receiving these vaccines she has not been able to use her arm.  Reports that she went to the neurologist who confirmed that she has nerve damage.
I received my second dose of the Pfizer Covid vaccine on 01-13-2021 at 8:30am in my left upper arm.  By 3pm that day, my left arm was very tender to the point I couldn?t lift it up and I began having whole body chills and shivering along with extreme fatigue. I went to bed at 5:30pm that night and woke up around 11:30pm to my whole body shaking and shivering and my teeth where chattering together. My husband said I was confused at that time and kept repeating that I was freezing. I must have had 5 blankets piled on top of me to try to get me to warm up.  By the next morning, I soaked through the bedsheets and had extreme fatigue (like I had a hard time keeping my eyes open) all over body aches, fever and chills.  I remained this way for the next week.  At the end of the 1st week I still had chills, extreme fatigue, nausea and horrible headaches and my left arm pain turned into left elbow joint pain. By the end of the 2nd week, I still had extreme fatigue, headaches and left elbow pain along with body tremors. On 1-28-2021, I went to the hospital due to having two episodes where I felt so dizzy I had to lay down on the ground until the dizzy spells subsided. I was given IV fluids and sent home with orders to rest. By the end of the 3rd week I no longer had body tremors or dizzy spells but I still had extreme fatigue needing multiple naps a day along with headaches at which time my primary doctor prescribed me Imitrex to help alleviate the headaches and I still had left elbow joint pain. I also developed bronchitis. It is now February 25, 2021 and I am still having fatigue and mild to moderate headaches along with the left elbow joint pain along with some right elbow joint pain. I have been out of work for over a month now due to my fatigue and joint pain.
Flu like symptoms; light fever; extreme fatigue; whole body soar; This is a spontaneous report from a contactable consumer, the mother.   A 19-years-old male patient received first dose of bnt162b2 (PFIZER BIONTECH COVID 19 VACCINE formulation: solution for injection, lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single (age at vaccination 19 years) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced flu like symptoms, whole body soar, light fever and extreme fatigue on an unknown date. It was reported that the patient does not take any medications and was a healthy young man and that event took place after use of product. The patient lab data included light fever. The reason for it being past the 24 hours was because it was my son. The reporter was the one observing him and the symptoms lasted more than two days. She thought it would be normal for him to have some symptoms so that was why she didn't report it right away. The patient received the vaccine on a Tuesday and then missed three days of work. By that Saturday he was back to normal. The outcome of the events was recovered on an unknown date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from an office manager concerning a 19 year old female patient who on 08-JUN-2009 was vaccinated with the first and only dose of GARDASIL. On an unknown date after receiving GARDASIL the patient experienced chills and dizziness for three days. It was reported that the patient will not receive further doses of GARDASIL. At the time of reporting the patient had recovered. Additional information has been requested.
Sweating, itchy back and abdomen, Patient was placed in recumbent position ,was given water and observed for 17 minutes and was sent home.
This case was reported by a lawyer and described the occurrence of joint pain in a 61 year old female pt who received lyme disease vaccine recombinant (Lymerix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unk time after receiving Lymerix, the pt experienced joint pain, clawing and other neurologic complaints and abnormal MRI (magnetic resonance imaging scan).  Time to onset, treatment, and outcome were not reported.
Acute Appendicitis which occurred 84 hours after injection of the Moderna covid vaccine #1.  Presented with right abdominal pain and required removal of appendix.
Patient was given vaccine in office on 3/5/20.  She developed a painful rash on the right upper chest in the C4 dermatome consistent with shingles.  Patient's husband (who is an ER MD) directly observed the rash and patient sent us pictures of the rash which looked consistent with shingles rash.
PT RECEIVE VACCINE ON 12/6/2022, ON 12/16/22 SHE CALLED AND SSTATED THAT SHE GOT HER FLU SHOT A WEEK AGO AND HER ARM HAS BEEN SORE AND HURTING WHEN SHE MOVES IT.  SHE WAS ENCOURAGED TO USE WARM COMPRESSES AND TYLENOL AS NEEDED.  PT DENIED ANY REDNESS OR FEVER IN THE ARM.  12/20/22 SHE CALLED BACK WILTH STILL HAVING PAIN IN THAT ARM/SHOULDER.  AN APPOINTMENT WAS MADE FOR MD TO EVALUATE.  1/10/23 SHE HAD AN XRAY OF THAT SHOULDER AND IT WAS WITHIN NORMAL LIMITS.  SHE WAS SEEN 1/13/23 WITH PAIN STILL.  SHE WAS STARTED ON MEDROL STEROID PACK AND REFERRED TO AN ORTHOPEDIST.
Dizziness, chills, shortness of breath and chest pain, fever of 102 degrees. Benadryl was given as treatment.
SWOLLEN ALMOND SHAPE SPOT UNDER RIGHT EYE; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included allergy to contrast dye. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced swollen almond shape spot under right eye. On 06-APR-2021, the subject experienced injection site pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from injection site pain, and had not recovered from swollen almond shape spot under right eye. This report was non-serious.
Pt was found dead @ aunt's home--in twin size bed, by foot of the bed--between rail on foot & mattress;
Sore arm, small lump at lymph node area on the same arm the shot was administered. By 8:00 PM on 07/12/2012 the lump swelled big enough to cause alarm. Followed up with regular doctor and he said to watch it and take Motrin. If pain gets worse and still persistent by Monday to come back in to doctors office.
This spontaneous report as received from a medical assistant refers to a male patient of unknown age. The medical assistant reported that the patient received all three doses of GARDASIL (lot#, dose, route not reported) but doses were given outside of recommended schedule in Pl. Patient received his first dose of GARDASIL on 28-NOV-2011, second dose on 07-NOV-2012 and third dose on 18-DEC-2013. No adverse effects reported. Additional information has been requested.
Information had been received on 19-APR-2017 regarding a case in litigation. It was alleged in litigation that a female patient of unknown age was vaccinated with ZOSTAVAX vaccine (dose, route, lot # and expiration date were not provided) on or about 06-JUL-2007 at a facility as recommended for routine adult health maintenance for the prevention of shingles. The patient's medical history, concurrent conditions and concomitant medication were not provided. It was reported, the ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 03-MAR-2013, the patient was treated at the same facility for an ongoing painful rash and persistent nerve pain which was diagnosed as shingles and the residual condition of post-herpetic neuralgia. Post-herpetic neuralgia is a painful and chronic condition caused by the residual nerve damage after the contracting shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. This is one of several reports from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1704USA009840: US-009507513-1704USA009757: US-009507513-1704USA009595: US-009507513-1704USA009664.
Injection site redness; Injection site swelling; Injection site hives; she had a few lumps further down her left arm; Injection site itching; This is a spontaneous report from a contactable consumer (patient).  A 90-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: ER8727, expiry date: unknown) via an unspecified route of administration, administered in arm left on 23Mar2021 12:20 as DOSE 1, SINGLE (age at the of vaccination was 90-years-old) for COVID-19 immunization. The patient's medical history included aneurysm of heart since either 1982 or 1983 and unknown if ongoing. Concomitant medications were not reported. Patient did not receive any vaccination within 4 weeks. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was none. Additional vaccines administered on same date of the Pfizer suspect was none. On 28Mar2021, the patient experienced injection site redness, injection site swelling, injection site hives, she had a few lumps further down her left arm, injection site itching. Patient reported her arm was a little red, the swelling was gone and there were a few lumps on her arm. Patient reported she had not been itching and patient thought allergic reaction has gone. Patient reported that her second COVID-19 VACCINE slot was scheduled on 17Apr2021 and was past 21 days recommended between first and second dose. Patient was not taken to Emergency Room and Physician Office. Patient received the treatment for events/therapeutic measures were taken patient took Benadryl 25mg tablet, Expiration Date: Oct2023. The outcome of events was injection site redness, injection site swelling was recovered on 29Mar2021, the outcome of event injection site itching was recovered on 30Mar2021, the outcome of she had a few lumps further down her left arm, injection site hives was recovering.  No follow-up attempts are possible. No further information was expected.
Hives all over the trunk of her body; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Mar-2021 and was forwarded to Moderna on 07-Mar-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of URTICARIA (Hives all over the trunk of her body) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced URTICARIA (Hives all over the trunk of her body). At the time of the report, URTICARIA (Hives all over the trunk of her body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 43-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 42 years for covid-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.   Clinical course: The patient did not have any known allergies. Relevant past drug history: Name of Drug as Reported was no, Reaction: Allergy. The patient did not take any other medications/products within 2 weeks of starting COVID-19 treatment. The patient previously received a COVID-19 Vaccine. Anti-viral details: product-COVID 19 Treatment, brand-Paxlovid, treatment start date-02Jun2022, treatment stop date-06Jun2022, indication-Treatment of COVID-19. Reported Event: The original COVID Symptoms came back. Since Monday I had the headache, sore throat and a couple of days later, my waist and hips started hurting (they feel stiff and achy). These were all COVID symptoms I had before taking Paxlovid. All the symptoms were gone when I finished the antiviral medication but came back days later. Also, one of the side effects of Paxlovid that I wasn't aware of is that it kept me awake. It gave me enough energy to keep me awake during the day and at night. I could not sleep throughout those 5 days that I took Paxlovid. Date of start of reaction/event: 12Jun2022. Outcome of reaction/event at the time of last observation: Not recovered/Not resolved. Hospitalization Prolonged: No  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Soreness at injection site; Gastrointestinal discomfort; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 12Apr2021 as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. On 13Apr2021, after vaccination the patient experienced soreness at injection site and gastrointestinal discomfort. The patient feeling much better 36 hours after the shot than before the shot, including resolution of symptoms from a prior COVID-19 infection, shortness of breath, lethargy, and brain fog that had been lingering for months prior to the vaccination. It was unknown if patient received treatment for the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. It was unknown if the patient been tested for COVID-19 since the vaccination. The clinical outcome of the events soreness at injection site and gastrointestinal discomfort was resolved on an unknown date of Apr2021.   No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Varivax, MMR given on 9/16/05. Developed fever 1 week later with 3 red papules. Developed ataxia that day.
presyncope, nausea, black spots in vision. Evaluated by EMS-Cleared
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients. In approximately 2015 (reported as since 13-MAR-2015), the patients were vaccinated with doses of ROTATEQ lot # K010221, K011663, K016313 and lot # reported as K015816 (expiration dates, dose, route and site of administrations were not reported) that were exposed to temperatures outside of the recommended range. No adverse effects had been observed or reported. Follow up information has been received from the reporting healthcare professional on 02-JUL-2015, who informed that a patient was vaccinated on 05-JUN-2015 with a dose of ROTATEQ lot # K016313, expiration date not reported, (administration route was not provided). According to the reporter the vaccine dose that was administered underwent a temperature excursion for 87 hours. This is one of several report from the same reporter. Additional information has been requested.
Information has been received from a physician concerning a 35 year old male with no medical history or allergies who on approximately 26-JUN-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). There was no concomitant medication. On approximately 29-JUN-2007, three days after vaccination the patient experienced varicella like rash. The patient was treated with Benadryl. At the time of report the patient was recovering with some lesions remaining. A product quality complaint was not involved. Additional information has been requested.
This spontaneous report was received fro ma 66 year old female retired medical assistant reporting on herself. The patient's allergies included allergy or reaction to penicillin. On 23-SEP-2015, the patient was vaccinated with a dose of ZOSTAVAX (dose, route, lot number and expiration date were not provided). Concomitant medication was not provided. On 24-SEP-2015, the patient experienced redness, warmth and tenderness at the injection site. The patient did not received treatment for the adverse events and did not seek medical attention. Laboratories studies were not performed. Subsequently, within a few days, the patient recovered from these symptoms. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 14-OCT-2012 13:48, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
8 hours after receiving my booster shot, I began to feel unwell, no appetite, slight temperature of 99 and extremely sore left arm. My temperature continued to rise until it reached 102.6 two hours laters. I had chills and shaking. My entire body ached. I had a temperature, chills, and body aches for several days and was unable to work. I took Tylenol every 6 hours to reduce my temperature. I was also very fatigued. One week later the symptoms subsided completely and I have felt well since.  FYI: My 92 year old father received his booster shot at the same time and had no adverse reaction.
21 year old male who presented to the Emergency Department on 6/11/21 with chief complaint of left anterior chest pain.  The patient received the second dose of Moderna COVID-19 vaccine on 6/9/21.  The patient's troponin was elevated upon admission to the hospital.  The patient remained hospitalized from 6/11 -  6/14/21 and was then discharged to home.  The patient was provided with colchicine and NSAIDs during hospital course.  Cardiac MRI report read as likely myocarditis on 6/14/21.
she is up to date all of the shots, all of the boosters and she had the Corona four times; she is up to date all of the shots, all of the boosters and she had the Corona four times; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "she is up to date all of the shots, all of the boosters and she had the Corona four times".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient has continued to have pain in her left shoulder. She has required physical therapy and cortisone shot and continues to experience pain in her shoulder on left. Continues with physical therapy. Diagnosed with encapsulated tendonitis.
I was diagnosed with triple negative breast cancer in my left breast on 4/8/22 and it was determined through genetic testing that I have no clinically significant variants.
No adverse event; incorrect Moderna covid19 strength vaccine given.  Reported to Nurse Practitioner.  Directed to re-vaccinate with correct Moderna covid19 vaccine dose.  Trying to contact parent, phone number listed is out of service.  Mailed a letter to parent to have them call our office to have them come in to re-vaccinate.
Daily headaches. Some last even after taking up to 800 mg of Ibuprofen.
Swelling, redness, itching of left upper arm within 48 hours of vaccine. Given Atarax and Omnicef.